Type D retrovirus was first isolated from a rhesus monkey (Macaea mulatta) in 1969 (Chopra & Mason, 1970) . The rhesus monkey is one of several species of macaque, an Asian Old World primate. This initial type D retrovirus isolate was called Mason-Pfizer monkey virus. It remained the only macaque type D retrovirus isolate available for study until 1984 when researchers at several U.S. Regional Primate Research Centers independently isolated other type D retroviruses in association with disease outbreaks in their macaque colonies Marx et al., 1984; Stromberg et al., 1984) . Type D retroviruses have now been isolated from at least six species of macaque. They cause an immunodeficiency/wasting syndrome in a varying percentage of recently infected macaque monkeys in both experimental and primate colony settings (Fine et al., 1975; Letvin et al., 1984; Marx et al., 1985; Desrosiers et al., 1985; Heidecker et al., 1987) . These macaque type D retroviruses have been well characterized. Five serotypes have now been identified that exhibit little or no crossneutralization (Marx et aL, 1985; P. Marx, personal communication) . Three serotypes of these related macaque type D retroviruses have been sequenced (Power et al., 1986; Sonigo et al., 1986; Thayer et al., 1987) .
Primate type D retroviruses have also been isolated from squirrel monkeys (Heberling et al., 1977) and langurs (Todaro et al., 1978 (Daniel et al., 1988; Shiigi et al., 1989) . At the California Regional Primate Research Center, type D retrovirus infection of macaques appears to be confined to only one of 11 corrals (Henrickson et al., 1983; Lerche et al., 1984 Lerche et al., , 1986 . At the Oregon Regional Primate Research Center, Celebes black macaques (Macaca nigra) were free of type D retrovirus infection until 1980 at which time it was accidentally introduced into the colony. By 1983 the prevalence of infection had risen to over 50~ and has remained there ever since (Shiigi et al., 1989) . These findings raise the possibility that many species of macaques may not be natural hosts for type D retrovirus infection but that they may have acquired their infection while in captivity. Possible sources of infection include other species of macaques or other non-human primates not yet identified.
In this report, we describe the presence of antibodies to type D retrovirus in African talapoin monkeys, confirming the earlier report of Lowenstein et al. (1986) with zoo talapoins. Other African non-human primates were negative for antibodies to type D retrovirus. These results indicate that talapoins are a potential reservoir of type D retrovirus infection.
Sera were obtained from various importers, from several zoos and from a captive colony of African green monkeys derived from the highlands of Ethiopia. Purification of retrovirus D/New England (D/NE), coating of plates and ELISA were performed as described previously using 1:20 dilutions of the sera (Daniel et al., 1988) . Goat antiserum to human Ig conjugated with alkaline phosphatase was used for the ELISA. p-Nitrophenylphosphate was used as the sub-strate and absorbance was recorded at 410 nm. All sera with absorbance values greater than 0.5 were further tested for immunoblot reactivity using purified retrovirus D/NE as antigen as described (Kodama et al., 1989) .
All 11 of the test sera with absorbance readings greater than 0.5, four test sera with values below 0.5 and assorted positive and negative rhesus monkey control sera were tested for immunoblot reactivity. Four of the test sera gave clear positive reactions (Fig. 1) . All four positive test sera, as well as the four positive control sera from experimentally infected rhesus monkeys, had ELISA values greater than 1.6 (Table 1 ). All four of the positive test sera were from talapoin monkeys caught in west Africa. These sera recognized p27 and p24 gag (capsid) antigens, the pl0 gag (matrix) protein and the gp20 env (transmembrane) protein. Weak reactivity to gp70 env, the external glycoprotein, could be due to underrepresentation of this antigen in the virus preparation, to a low level of antibodies to this antigen and/or weak cross-reaction to this most variable protein. Additional immunoblot tests showed the presence of IgG but not IgM antibodies reactive to the type D retrovirus protein in the talapoin sera. Immunoblot reactivity was considerably stronger with serotype 1 than serotype 2 (data not shown). The specific recognition pattern of D/NE retrovirus proteins by the talapoin sera may signify viral proteins most strongly cross-reactive with the putative talapoin virus. Although many of the 154 sera tested in this survey were positive for antibodies to the simian immunodeficiency virus (SIV), all four talapoin sera were negative for antibodies to SIV.
Our results suggest that type D retrovirus infection is endemic in talapoin monkeys in western Africa. Characterization of the virus they carry must await the first isolation. Characterization of talapoin type D retrovirus and prevalence studies of infection in assorted macaque species and populations in their native habitats will help clarify the origins of type D retrovirus infections in captive colonies.
